Sophia Fedorowicz, a Master’s student at Staffordshire University, with a background in psychology, looks at the latest Cochrane Reviews are systematic reviews. In systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. on psychological therapies for treatment-resistant depression in adults. Sophia spent four weeks on elective at Cochrane UK during June 2018.
What is Treatment-Resistant Depression?
To give an idea of the The proportion of a population who have a particular condition or characteristic. For example, the percentage of people in a city with a particular disease, or who smoke. of depression (also known as unipolar, or major depression), Papadimitropoulou et al (2017) states that in a lifetime depression affects around 15% of the general The group of people being studied. Populations may be defined by any characteristics e.g. where they live, age group, certain diseases. of high-income countries and 11% of low-income countries. According to the World Health organisation there were 300 million people living with depression in 2017, an increase of more than 18% since 2005 (WHO, 2017).
The Diagnostic and Statistical Manual of Mental Disorders, fifth edition, (DSM-V) characterises depression as having symptoms such as depressed mood, loss of pleasure or interest in doing things, significant weight loss or weight gain, insomnia or hypersomnia, as well as many others, persistent over the course of two weeks and not attributable to any other cause e.g. another medical condition. The first line Something done with the aim of improving health or relieving suffering. For example, medicines, surgery, psychological and physical therapies, diet and exercise changes. for adults presenting with these symptoms are antidepressants; which do not come without side effects (NICE, 2009), unfortunately 10-30% (Al-Harbi, 2012) of people with depression do not respond to this treatment and are considered to be ‘treatment-resistant’ (Balestri et al, 2016).
There is disagreement about the definition of treatment-resistant depression (TRD). Descriptions range from a non-response to a single antidepressant all the way to a lack of response to multiple antidepressants of different classes and combinations. Worryingly, the prevailing definitions of TRD do not include a lack of response to psychological treatments. TRD has been associated with lower quality of life and poorer Outcomes are measures of health (for example quality of life, pain, blood sugar levels) that can be used to assess the effectiveness and safety of a treatment or other intervention (for example a drug, surgery, or exercise). In research, the outcomes considered most important are ‘primary outcomes’ and those considered less important are ‘secondary outcomes’. compared to their non-resistant counterparts (Eisendrath et al, 2015); this fact, and the prevalence of depression, reflects the importance of further investigation.
So, what’s the next step?
Once a person is identified as having unipolar TRD, NICE guidelines (2009) recommend increasing the dose of antidepressant, switching to a different antidepressant, or trying another pharmacological or psychological approach. To give an idea of what this may involve, selective serotonin reuptake inhibitors are the current first choice of antidepressant drugs, followed by serotonin and noradrenaline reuptake inhibitors. Others include monoamine oxidase inhibitors and tricyclic antidepressants. Some non-pharmacological treatments besides psychological therapy are electroconvulsive therapy (a last resort treatment) and transcranial magnetic stimulation (Papadimitropoulou et al, 2017). That’s a lot of options and combinations. There is also research investigating the possibility of other drugs to alleviate TRD symptoms, one such drug is ketamine. Interesting, but what about psychological therapy?
The report of the Special Rapporteur, UN Human Rights Council, stated in 2017:
While psychotropic medications can be helpful, not everyone reacts well to them and in many cases they are not needed. Prescribing psychotropic medications, not because they are needed, but because effective psychosocial and public health interventions are not available, is incompatible with the right to health (Puras, 2017)
The Cochrane Review ‘Psychological therapies for treatment-resistant depression in adults’ (Ijaz et al., 2018) synthesised evidence from primary studies investigating psychological therapies and TRD. The psychological interventions included in the review are: cognitive behavioural therapy (CBT) which focuses on unrealistic, unhelpful thoughts and maladaptive patterns of behaviour; dialectical behavioural therapy, which is based on CBT but has been adapted to help individuals who feel emotions more intensely; interpersonal therapy, a form of psychotherapy focused on relationships with others; and intensive short-term dynamic psychotherapy, a form of psychotherapy used to treat a broad range of emotional disorders.
Six Randomization is the process of randomly dividing into groups the people taking part in a trial. One group (the intervention group) will be given the intervention being tested (for example a drug, surgery, or exercise) and compared with a group which does not receive the intervention (the control group). A trial in which a group (the ‘intervention group’) is given a intervention being tested (for example a drug, surgery, or exercise) is compared with a group which does not receive the intervention (the ‘control group’). were included with a total of 698 participants, aged 18 to 74. Each person had a diagnosis of unipolar depression that had not responded to antidepressants at the recommended dose over a minimum of four weeks. All included studies compared usual care alongside psychological therapy to usual care alone. The results of this review show there is moderate-quality evidence that, given in addition to usual care, psychological therapy produced improvements in depressive symptoms for people with TRD over the short term (up to six months). Low-quality evidence shows lower depression scores over 12 and 46 months. Two of the studies reported serious adverse effects in the usual care group: one suicide, one hospitalisation and two people experienced worsening of symptoms. There were no reports of adverse effects in the A treatment, procedure or programme of health care that has the potential to change the course of events of a healthcare condition. Examples include a drug, surgery, exercise or counselling. groups.
The review comments that studies involving participants with co-morbid physical and psychological disorders were included so long as the psychological therapy was being primarily used to manage TRD not the The presence of one or more diseases or conditions other than those of primary interest. In a study looking at treatment for one disease or condition (for example, heart disease), some of the individuals may have other diseases or conditions that could affect their outcomes (e.g. diabetes).. Mental disorders are complex and depression is often accompanied by other disorders such as anxiety. Ignoring the co-morbid disorder and asserting that the treatment will only affect the TRD symptoms is difficult to justify.
Outcomes were measured by rating scales for depression using either clinician rated scales such as the Hamilton rating scale for depression (Hamilton, 1960); Montgomery-Asberg Depression rating Scale (Montgomery, 1979); or self-report rated scales (Beck Depression Inventory, Beck 1961, Beck 1996). These outcomes may not accurately reflect an individual’s progress for two reasons. The first is that self-report can be an unreliable impression because in psychological interventions it is very difficult to blind patients and therapists to the intervention being provided, therefore all six included studies were at high A way of expressing the chance of an event taking place, expressed as the number of events divided by the total number of observations or people. It can be stated as ‘the chance of falling were one in four’ (1/4 = 25%). This measure is good no matter the incidence of events i.e. common or infrequent. of performance Any factor, recognised or not, that distorts the findings of a study. For example, reporting bias is a type of bias that occurs when researchers, or others (e.g. drug companies) choose not report or publish the results of a study, or do not provide full information about a study.. The second reason is that in purely quantitative measures the nuances of symptom improvement are missed. The scores of an individual may not have markedly changed but that does not mean that there has been no improvement. Depression as a disorder can have deep rooted causes and it may be that more time is required, or a different psychological therapy is needed for that unique individual.
The results of the review should be applied cautiously as three of the six studies were small, recruiting less than 50 participants and most participants in the review overall were women. Nakagawa (2017) was the only included An investigation of a healthcare problem. There are different types of studies used to answer research questions, for example randomised controlled trials or observational studies. that recruited more men than women. This gender imbalance may reflect the higher risk of depression in females (see Kuehner, 2003). Three of the studies used CBT, making that particular therapy over represented in the sample. Finally, it may not be appropriate to compare cognitive behaviour therapy outcomes with interpersonal therapy outcomes or dialectical behavioural therapy outcomes as each psychological therapy has been developed to address a specific need, not to be broadly applied to every symptom.
The Cochrane Reviews are systematic reviews. In systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. concludes that the addition of psychological therapy to usual care is beneficial for people with TRD over the short term. Further evidence is needed on the The ability of an intervention (for example a drug, surgery, or exercise) to produce a desired effect, such as reduce symptoms. of different types of psychological therapies for people with TRD and there is currently a gap in the evidence as to whether switching to psychological therapy alone is more beneficial than continuing with antidepressants.
The fact that antidepressants are a first line treatment for depression and that psychological therapy is not even considered by definitions of TRD is indicative of a standardised medical model treatment programme for unipolar depression regardless of potential co-morbidities or contributing psychosocial or environmental factors. Much more research needs to be done with regards to types of psychological therapies and the specifics of individual symptoms and co-morbidities to enable a freedom of informed choice for patients and effective treatment.
For me as a student, this review has highlighted two elements. The first is the importance of doing In systematic reviews we search for and summarize studies that answer a specific research question (e.g. is paracetamol effective and safe for treating back pain?). The studies are identified, assessed, and summarized by using a systematic and predefined approach. They inform recommendations for healthcare and research. because they highlight gaps in research which are potentially of great importance. The second is that when it comes to the issue of appropriate mental health treatments there is still a long way to go, but the work has begun and that’s an exciting prospect for the future of mental health treatment.
Join in the conversation on Twitter with @CochraneUK or leave a comment on the blog.
Sophia Fedorowicz has nothing to disclose.
This blog was originally posted on Students 4 Best Evidence.